Protein Therapeutics Market: Global Report 2022 – Key Companies, Products, and Industry Analysis

on
The latest trending report published by Crystal Market Research titled, Protein Therapeutics Market, approximates that the Protein Therapeutics market size is estimated to flourish at a significant CAGR in the future, and this is attributed to the escalation in need for this product across the globe along with novel innovations in the market.
The Protein Therapeutics Market was worth USD 123.54 billion in the year of 2012 and is expected to reach approximately USD 241 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 6.91% during the forecast period. Therapeutic proteins are a critical class of pharmaceuticals, which are managed to treat a variety of various diseases, for example, infectious diseases, cancer, and others. These medications hold critical potential to enhance human health. The requirement for protein therapeutics has expanded impressively, attributable to increment in predominance of chronic diseases and advancement of plasma-determined treatments.
Market Key Players:
Roche Holding AG
Pfizer
Johnson & Johnson
Baxter International
Abbott Laboratories
Eli Lilly and Company
Novo Nordisk.
On the basis of application the Protein Therapeutics Market is segmented into Immunologic Disorders, Cancer, Genetic Disorders, Metabolic Disorders, Hematological Disorders and Hormonal Disorders. Therapeutic protein drugs are an imperative class of prescriptions serving patients most needing novel treatments. Protein therapeutics has been produced to treat a wide range of clinical issues such as genetic disorders, cancer, exposure to infectious agents and inflammation.
The global Protein Therapeutics Market is segmented as follows-
By Product:
Monoclonal Antibodies
Fusion Protein
Interferon
Follicle Stimulating Hormone
Insulin
Erythropoietin
Human Growth Hormone
By Application:
Metabolic Disorders
Hematological Disorders
Hormonal Disorders
Immunologic Disorders
Cancer
Genetic Disorders
Others

Comments

Post a Comment